全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Catalyst-Free Synthesis of Highly Biologically Active 5-Arylidene Rhodanine and 2,4-Thiazolidinedione Derivatives Using Aldonitrones in Polyethylene Glycol

DOI: 10.1155/2013/273534

Full-Text   Cite this paper   Add to My Lib

Abstract:

A green, efficient synthesis of 5-arylidene rhodanine and 2,4-thiazolidinedione derivatives without using any external catalyst in polyethylene glycol (PEG) at 80°C has been described. Reaction procedure is very simple, short, and obtained yields are very high. 1. Introduction Rhodanines and thiazolidinediones both are aprivileged class of molecule, and they show large number of biological activities. The most significant position of these molecules seems to be as they are asubset of commercially employed noninsulin-dependent diabetes mellitus (NIDDM), insulin sensitizing agents (Figure 1) such as epalrestat, ciglitazone, AD-5061, pioglitazone, rosiglitazone, and so forth. Figure 1: Clinically used molecules having 5-arylidene rhodanines and 2,4-thiazolidenediones. Furthermore, rhodanine derivatives possess anticonvulsant, antibacterial, antiviral, and antidiabetic activities [1–3] Some of rhodanine-based derivatives act as hepatitis C virus (HCV) protease inhibitor [4], uridine diphospho-N-acetylmuramate/L-alanine ligase inhibitor [5], aldose reductase [6], β-lactamase [7], and JNK-stimulating phosphatase-1 (JSP-1) [8], while some of its derivatives are used for the analysis of certain noble metal ions [9]. Therefore, the synthesis of rhodanine derivatives currently is of much importance and a variety of methods and catalysts have been used [10–12]. Unlike rhodanine, 2,4-thiazolidinedione derivatives also have remarkable biological activities like antidiabetic [13], antibacterial [14], antifungal [15], antiproliferative effect on vascular smooth muscle [16], aldose reductase inhibitors [17], 15-hydroxyprostaglandin dehydrogenase inhibitors [18] instead of these biological activities 5-benzylidene-thiazolidine-2,4-dione derivatives act as inhibitors of MurD ligase [19]. In the literature several methods have been reported to synthesize these privileged molecules [20–24]. Therefore, significant biological activities prompt us to synthesize thiozolidine derivatives. Nitrones (imine oxides) are reputed as 1,3-dipoles and are extensively explored for the synthesis of five membered heterocycles by combining them with several types of multiple bonds [25–27]. Apart from this major utility their general chemistry is little studied.[27] There are few reports of successful 1,3-additions of nitrones [28, 29]. Yousif et al. reported reactions of heterocyclic N-oxides under acidic conditions and obtained only condensed products [30]. In contrast, their counterpart imines are extensively explored to expose their utility as aldehyde equivalent [31–33]. Present

References

[1]  M. Yu, M. Kanji, I. Hitoshi, H. Chitoshi, O. Satoru, and S. Takashi, “Studies on antidiabetic agents—10. Synthesis and biological activities of pioglitazone and related compounds,” Chemical & Pharmaceutical Bulletin, vol. 39, no. 6, pp. 1440–1445, 1991.
[2]  J. H. Ahn, S. J. Kim, W. S. Park et al., “Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 11, pp. 2996–2999, 2006.
[3]  M. Sortino, P. Delgado, S. Juárez et al., “Synthesis and antifungal activity of (Z)-5-arylidenerhodanines,” Bioorganic and Medicinal Chemistry, vol. 15, no. 1, pp. 484–494, 2007.
[4]  T. S. Wan, L. L. Cheng, L. Y. Su, P. L. Siew, and M. S. Mui, “Arylalkylidene rhodanine with bulky and hydrophobic functional group as selective HCV NS3 protease inhibitor,” Bioorganic & Medicinal Chemistry Letters, vol. 11, pp. 91–94, 2001.
[5]  M. M. Sim, S. B. Ng, A. D. Buss, S. C. Crasta, K. L. Goh, and S. K. Lee, “Benzylidene rhodanines as novel inhibitors of UDP-N-acetylmuramate/L-alanine ligase,” Bioorganic & Medicinal Chemistry Letters, vol. 12, no. 4, pp. 697–699, 2002.
[6]  R. MacCari, A. D. Corso, M. Giglio, R. Moschini, U. Mura, and R. Ottan, “In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors,” Bioorganic & Medicinal Chemistry Letters, vol. 21, no. 1, pp. 200–203, 2011.
[7]  E. B. Grant, D. Guiadeen, E. Z. Baum et al., “The synthesis and SAR of rhodanines as novel class C β-lactamase inhibitors,” Bioorganic & Medicinal Chemistry Letters, vol. 10, no. 19, pp. 2179–2182, 2000.
[8]  S. C. Neil, O. Christine, and P. Marina, “Rhodanine derivatives as inhibitors of JSP-1,” Bioorganic & Medicinal Chemistry Letters, vol. 15, pp. 3374–3379, 2005.
[9]  E. Tang, G. Yang, and J. Yin, “Studies on the synthesis of 5-(p-aminobenzylidene)-rhodanine and its properties,” Spectrochimica Acta Part A, vol. 59, no. 3, pp. 651–656, 2003.
[10]  D. A. Heerding, L. T. Christmann, T. J. Clark et al., “New benzylidenethiazolidinediones as antibacterial agents,” Bioorganic and Medicinal Chemistry Letters, vol. 13, no. 21, pp. 3771–3773, 2003.
[11]  Z. Jian-Feng, Z. Feng-Xia, S. Yuan-Zhi, and Z. Yu-Lan, “Synthesis of 5-arylalkylidenerhodanines catalyzed by tetrabutylammonium bromine in water under microwave irradiation,” Archive for Organic Chemistry, vol. 14, pp. 175–180, 2006.
[12]  C. L. Lee and M. M. Sim, “Solid-phase combinatorial synthesis of 5-arylalkylidene rhodanine,” Tetrahedron Letters, vol. 41, no. 30, pp. 5729–5732, 2000.
[13]  B. C. C. Cantello, M. A. Cawthorne, G. P. Cottam et al., “[[ω-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents,” Journal of Medicinal Chemistry, vol. 37, no. 23, pp. 3977–3985, 1994.
[14]  I. M. Labouta, H. M. Salama, N. H. Eshba, O. Kader, and E. El-chrbini, “Potential anti-microbial: syntheses and in vitro anti-microbial evaluation of some 5-arylazo-thiazolidones and related compounds,” European Journal of Medicinal Chemistry, vol. 22, pp. 485–489, 1987.
[15]  R. Ottanà, R. MacCari, M. L. Barreca et al., “5-Arylidene-2-imino-4-thiazolidinones: design and synthesis of novel anti-inflammatory agents,” Bioorganic and Medicinal Chemistry, vol. 13, no. 13, pp. 4243–4252, 2005.
[16]  J. D. Peuler, S. M. Phare, A. R. Iannucci, and M. J. Hodorek, “Differential inhibitory effects of antidiabetic drugs on arterial smooth muscle cell proliferation,” American Journal of Hypertension, vol. 9, pp. 188–192, 1996.
[17]  G. Bruno, L. Costantino, C. Curinga et al., “Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones,” Bioorganic and Medicinal Chemistry, vol. 10, no. 4, pp. 1077–1084, 2002.
[18]  Y. Wu, S. Karna, C. H. Choi et al., “Synthesis and biological evaluation of novel thiazolidinedione analogues as 15-hydroxyprostaglandin dehydrogenase inhibitors,” Journal of Medicinal Chemistry, vol. 54, no. 14, pp. 5260–5264, 2011.
[19]  Z. Nace, T. Tihomir, S. Roman, et al., “Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2, 4-dione inhibitors of MurD ligase,” Journal of Medicinal Chemistry, vol. 53, no. 18, pp. 6584–6594, 2010.
[20]  M. A. Ibrahim, M. A. M. Abdel-Hamed, and N. M. El-Gohary, “A new approach for the synthesis of bioactive heteroaryl thiazolidine-2,4-diones,” Journal of the Brazilian Chemical Society, vol. 22, no. 6, pp. 1130–1139, 2011.
[21]  S. Mahalle, D. Ligampalle, and R. Mane, “Microwave-assisted synthesis of some 2,4-thiazolidinedione derivatives,” Heteroatom Chemistry, vol. 20, no. 3, pp. 151–156, 2009.
[22]  D. H. Yang, B. Y. Yang, Z. C. Chen, and S. Y. Chen, “A convenient synthesis of 5-arylidenethiazolidine-2,4-diones on potassium fluoride-aluminium oxide,” Organic Preparations and Procedures International, vol. 38, no. 1, pp. 81–85, 2006.
[23]  B. Y. Yang and D. H. Yang, “Solvent-free synthesis of 5-benzylidene-2-thioxothiazolidin-4-ones and thiazolidine-2,4-diones catalysed by glycine under microwave irradiation,” Journal of Chemical Research, vol. 35, no. 4, pp. 238–239, 2011.
[24]  K. F. Shelke, S. B. Sapkal, B. R. Madje, B. B. Shingate, and M. S. Shingare, “Ionic liquid promoted an efficient synthesis of 5-arylidene-2,4-thiazolidinedione,” Bulletin of the Catalysis Society of India, vol. 8, pp. 30–34, 2009.
[25]  A. Padwa, Ed., 1,3-Dipolar Cycloaddition Chemistry, Wiley-Interscience, New York, NY, USA, 1984.
[26]  K. B. G. Torssell, Nitrile Oxides, Nitrones, and Nitronate in Organic Synthesis, VCH, New York, NY, USA, 1988.
[27]  A. Banerji and P. Sengupta, “Recent studies on 1,3-dipolar cycloadditions of nitrones,” Journal of the Indian Institute of Science, vol. 81, no. 3, pp. 313–323, 2001.
[28]  T. Okino, Y. Hoashi, and Y. Takemoto, “Thiourea-catalyzed nucleophilic addition of TMSCN and ketene silyl acetals to nitrones and aldehydes,” Tetrahedron Letters, vol. 44, no. 14, pp. 2817–2821, 2003.
[29]  S. I. Murahashi, Y. Imada, T. Kawakami, K. Harada, Y. Yonemushi, and N. Tomita, “Enantioselective addition of ketene silyl acetals to nitrones catalyzed by chiral titanium complexes. Synthesis of optically active β-amino acids,” Journal of the American Chemical Society, vol. 124, no. 12, pp. 2888–2889, 2002.
[30]  M. M. Yousif, S. Seitaro, and H. Masatomo, “Studies on tertiary amine oxides—72. Reactions of aromatic N-oxides with Meldrum's acid in the presence of acetic anhydride,” Chemical & Pharmaceutical Bulletin, vol. 30, no. 5, pp. 1680–1691, 1982.
[31]  R. Chiba and T. Oriyama, “A highly stereoselective knoevenagel reaction of N-tosylimines with active methylene compounds in DMSO,” Chemistry Letters, vol. 37, no. 12, pp. 1218–1219, 2008.
[32]  A. M. Ramadan, M. A. Khadijah, A. Asma, and U. S. Kamal, “Solar thermochemical reactions—4: unusual reaction of nitrones with acetonitrile derivatives induced by solar thermal energy,” Green and Sustainable Chemistry, vol. 1, no. 4, pp. 176–181, 2011.
[33]  S. Patai, The Chemistry of the Carbon-Nitrogen Double Bond, Interscience, London, UK, 1970.
[34]  H. Jan and M. Anthony, “Nitrones,” Chemical Reviews, vol. 64, pp. 473–495, 1964.
[35]  K. Gong, Z.-W. He, Y. Xu, D. Fang, and Z.-L. Liu, “Green synthesis of 5-benzylidene rhodanine derivatives catalyzed by 1-butyl-3-methyl imidazolium hydroxide in water,” Monatshefte für Chemie, vol. 139, pp. 913–915, 2008.
[36]  K. F. Shelke, S. B. Sapkal, B. R. Madje, B. B. Shingate, and M. S. Shingare, “Ionic liquid promoted an efficient synthesis of 5-arylidene-2,4-thiazolidinedione,” Bulletin of the Catalysis Society of India, vol. 8, pp. 30–34, 2009.
[37]  Y. Zhang and Z. Zhou, “A solvent-free protocol for the green synthesis of 5-arylidene-2,4-thiazolidinediones using ethylenediamine diacetate as catalyst,” Organic Chemistry International, vol. 2012, Article ID 194784, 5 pages, 2012.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413